HCA INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud

Kirby McInerney LLP is investigating potential claims against HCA Healthcare, Inc. (“HCA Healthcare” or the “Company”) (NYSE: HCA) concerning possible violations of federal securities laws or other unlawful business practices. On July 14, 2026, HCA Healthcare issued a press release reporting preliminary financial and operating results for the second quarter of 2026. The company sharply lowered its full-2026 profit guidance, citing an unfavorable shift in the Company’s payer mix, driven by an increase in uninsured volume, which impacted revenue by approximately $400 million in the quarter. The Company lowered its forecast for 2026 earnings to between $28.70 and $30.50 a share and narrowed its revenue target to $77 billion to $79.5 billion. Adjusted earnings before interest, taxes, depreciation and amortization are targeted at between $15.4 billion and $16.1 billion. On this news, HCA Healthcare’s stock price fell $27.14 per share, or 6.95%, to close at $363.60 per share on July 14, 2026. No lawsuit has been filed yet, and the investigation is ongoing.